Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.09)
# 1,589
Out of 5,032 analysts
812
Total ratings
37%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Reiterated: Buy | $115 | $109.72 | +4.81% | 62 | Oct 7, 2026 | |
| CBIO Crescent Biopharma | Upgraded: Buy | $36 | $13.57 | +165.29% | 10 | Oct 6, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $9.76 | +53.69% | 25 | Oct 6, 2026 | |
| ALMS Alumis | Reiterated: Buy | $15 | $6.93 | +116.45% | 26 | Oct 5, 2026 | |
| EVMN Evommune | Reiterated: Hold | n/a | $6.61 | - | 10 | Oct 5, 2026 | |
| GENB Generate Biomedicines | Reiterated: Buy | $30 | $13.80 | +117.39% | 6 | Oct 5, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $25 | $9.87 | +153.29% | 2 | Oct 5, 2026 | |
| INCY Incyte | Reiterated: Buy | $152 | $112.73 | +34.84% | 23 | Oct 5, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Sell | $5 | $17.31 | -71.11% | 36 | Oct 5, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $65 | $18.72 | +247.22% | 65 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $6.75 | +270.37% | 25 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.31 | - | 40 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $6.16 | +305.84% | 22 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $44.00 | +127.27% | 34 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $80.18 | +49.66% | 20 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.49 | +369.80% | 6 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $29 | $20.24 | +43.28% | 39 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $344 | $226.05 | +52.18% | 4 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $8.61 | +422.65% | 26 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $56.22 | +6.72% | 16 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 575.00 | kr 428.60 | +34.16% | 9 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $12.37 | +102.10% | 17 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $16.33 | +267.42% | 2 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $54.00 | +48.15% | 19 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.60 | +88.68% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.99 | +212.89% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.32 | +278.79% | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $25.45 | +155.40% | 35 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $19.55 | +130.18% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $13.59 | +120.75% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.73 | +83.15% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $11 | $2.56 | +329.69% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $3.30 | +203.03% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.89 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.58 | +55.34% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.03 | +582.93% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $3.96 | n/a | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $7.08 | n/a | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.85 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8288 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $5.01 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $2.46 | n/a | 6 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7451 | n/a | 8 | Aug 11, 2023 |
Halozyme Therapeutics
Oct 7, 2026
Reiterated: Buy
Price Target: $115
Current: $109.72
Upside: +4.81%
Crescent Biopharma
Oct 6, 2026
Upgraded: Buy
Price Target: $36
Current: $13.57
Upside: +165.29%
Korro Bio
Oct 6, 2026
Reiterated: Buy
Price Target: $15
Current: $9.76
Upside: +53.69%
Alumis
Oct 5, 2026
Reiterated: Buy
Price Target: $15
Current: $6.93
Upside: +116.45%
Evommune
Oct 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.61
Upside: -
Generate Biomedicines
Oct 5, 2026
Reiterated: Buy
Price Target: $30
Current: $13.80
Upside: +117.39%
Monte Rosa Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $25
Current: $9.87
Upside: +153.29%
Incyte
Oct 5, 2026
Reiterated: Buy
Price Target: $152
Current: $112.73
Upside: +34.84%
Sarepta Therapeutics
Oct 5, 2026
Reiterated: Sell
Price Target: $5
Current: $17.31
Upside: -71.11%
Legend Biotech
Sep 30, 2026
Reiterated: Buy
Price Target: $65
Current: $18.72
Upside: +247.22%
Sep 30, 2026
Reiterated: Buy
Price Target: $25
Current: $6.75
Upside: +270.37%
Sep 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.31
Upside: -
Sep 25, 2026
Reiterated: Buy
Price Target: $25
Current: $6.16
Upside: +305.84%
Sep 24, 2026
Reiterated: Buy
Price Target: $100
Current: $44.00
Upside: +127.27%
Sep 24, 2026
Reiterated: Buy
Price Target: $120
Current: $80.18
Upside: +49.66%
Sep 23, 2026
Reiterated: Buy
Price Target: $7
Current: $1.49
Upside: +369.80%
Sep 22, 2026
Reiterated: Buy
Price Target: $30 → $29
Current: $20.24
Upside: +43.28%
Sep 16, 2026
Reiterated: Buy
Price Target: $344
Current: $226.05
Upside: +52.18%
Sep 11, 2026
Reiterated: Buy
Price Target: $45
Current: $8.61
Upside: +422.65%
Sep 10, 2026
Reiterated: Hold
Price Target: $60
Current: $56.22
Upside: +6.72%
Sep 10, 2026
Reiterated: Buy
Price Target: kr 575.00
Current: kr 428.60
Upside: +34.16%
Sep 9, 2026
Reiterated: Buy
Price Target: $25
Current: $12.37
Upside: +102.10%
Sep 3, 2026
Reiterated: Buy
Price Target: $60
Current: $16.33
Upside: +267.42%
Aug 31, 2026
Reiterated: Buy
Price Target: $80
Current: $54.00
Upside: +48.15%
Aug 14, 2026
Reiterated: Buy
Price Target: $20
Current: $10.60
Upside: +88.68%
Aug 14, 2026
Reiterated: Buy
Price Target: $25
Current: $7.99
Upside: +212.89%
Aug 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.32
Upside: +278.79%
Aug 12, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $25.45
Upside: +155.40%
Aug 11, 2026
Reiterated: Buy
Price Target: $45
Current: $19.55
Upside: +130.18%
Aug 7, 2026
Reiterated: Buy
Price Target: $35 → $30
Current: $13.59
Upside: +120.75%
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $2.73
Upside: +83.15%
May 11, 2026
Reiterated: Buy
Price Target: $17 → $11
Current: $2.56
Upside: +329.69%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $3.30
Upside: +203.03%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.89
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $2.58
Upside: +55.34%
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.03
Upside: +582.93%
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $3.96
Upside: n/a
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $7.08
Upside: n/a
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $16.85
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.8288
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $5.01
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $2.46
Upside: n/a
Aug 11, 2023
Reiterated: Hold
Price Target: n/a
Current: $0.7451
Upside: n/a